Identification of miR-20b-5p as an inhibitory regulator in cardiac differentiation via TET2 and DNA

Ke-Xin Li1, Jia-Ru Li1, Sheng-Jia Zuo2

  • 1Affiliated Qingyuan Hospital, Qingyuan People's Hospital, Guangzhou Municipal and Guangdong Provincial Key Laboratory of Molecular Target & Clinical Pharmacology, School of Pharmaceutical Science, Guangzhou Medical University, Guangzhou, 511436, China.

Clinical Epigenetics
|March 16, 2024
PubMed
Abstract

Insights

MicroRNA-20b-5p (miR-20b-5p) inhibits human embryonic stem cell cardiac differentiation by targeting TET2. This finding suggests miR-20b-5p may serve as a biomarker for atrial septal defect (ASD).

Area of Science:

  • Developmental Biology
  • Epigenetics
  • Cardiovascular Research

Background:

  • Congenital heart disease (CHD) lacks effective early diagnosis and intervention.
  • MicroRNAs (miRNAs) are epigenetic regulators crucial for cardiac development and potential CHD biomarkers.
  • Mechanisms of miRNA regulation in cardiac development and CHD are not fully understood.

Purpose of the Study:

  • To investigate the role of microRNA-20b-5p (miR-20b-5p) in cardiac development.
  • To explore the involvement of miR-20b-5p in the pathogenesis of congenital heart disease (CHD).

Main Methods:

  • Utilized miRNA expression profiling in human embryonic stem cells (hESCs) during cardiac differentiation.
  • Analyzed plasma samples from atrial septal defect (ASD) patients.
  • Investigated the regulatory relationship between miR-20b-5p, TET2, and cardiac transcription factors using knockdown and inhibition experiments.

Main Results:

  • miR-20b-5p was downregulated during hESC cardiac differentiation but upregulated in ASD patients.
  • miR-20b-5p suppressed hESC cardiac differentiation by targeting TET2 and reducing key cardiac transcription factors.
  • TET2 knockdown inhibited cardiac differentiation, partially rescued by miR-20b-5p inhibition.

Conclusions:

  • miR-20b-5p acts as an inhibitory regulator of hESC-derived cardiac differentiation via TET2 targeting.
  • miR-20b-5p shows potential as a diagnostic biomarker for atrial septal defect (ASD).

Related Concept Videos

Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.9K
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
9.8K
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
3.0K
General Transcription Factors01:30

General Transcription Factors

Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
5.3K
Combinatorial Gene Control02:33

Combinatorial Gene Control

Combinatorial gene control is the synergistic action of several transcriptional factors to regulate the expression of a single gene. The absence of one or more of these factors may lead to a significant difference in the level of gene expression or repression.
The expression of more than 30,000 genes is controlled by approximately 2000-3000 transcription factors. This is possible because a single transcription factor can recognize more than one regulatory sequence. The specificity in gene...
8.3K
Genomic Imprinting and Inheritance02:30

Genomic Imprinting and Inheritance

Diploid organisms inherit genetic material through chromosomes from both parents. Copies of the same gene are known as alleles. In most cases, both alleles are simultaneously expressed and allow various cellular processes to function optimally. If one of the alleles is missing or mutated, the expression of the other allele can compensate; however, this is not true for all genes.
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
34.4K